Jurors in New York began deliberating Monday in the federal securities fraud trial of former pharmaceutical CEO Martin Shkreli, who is accused with looting his own drug company to pay back disgruntled investors in two failed hedge funds he ran.
from CBC | Health News http://ift.tt/2uNy7SF
Aucun commentaire:
Enregistrer un commentaire